Potential for SSRIs as monotherapy for comorbid psychiatric disorders

Robert M.A. Hirschfeld

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The majority of patients with depression also will suffer from a comorbid anxiety disorder that may include panic disorder, obsessive-compulsive disorder, social phobia, or generalized anxiety disorder. The selective-serotonin reuptake inhibitors present an alternative and useful monotherapy in patients with depression and comorbid anxiety disorders. This treatment is likely to be highly cost-effective as well.

Original languageEnglish (US)
Pages (from-to)1047-1050
Number of pages4
JournalAmerican Journal of Managed Care
Volume2
Issue number8
StatePublished - Dec 1 1996

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'Potential for SSRIs as monotherapy for comorbid psychiatric disorders'. Together they form a unique fingerprint.

  • Cite this